Questo sito utilizza cookie tecnici  per migliorare la tua esperienza e offrire servizi in linea con le tue preferenze. Chiudendo questo banner, scorrendo questa pagina o cliccando qualunque suo elemento acconsenti all'uso dei cookie

dante280x250 babele280x250 busa280x250 libri280x250

Pubblicazioni scientifiche

1. Franceschi A, Tuccori M, Bocci G, Di Paolo A, Vannozzi F, Barbara C, Lastella M, Blandizzi C, Del Tacca M. Drug therapeutic failure in emergency department patients. A university hospital experience. Pharmacol Res 2004 Jan;49(1):85-91 
2. Bocci G, Tuccori M, Emmenegger U, Liguori V, Kerbel RS, Del Tacca M. Cyclophosphamide-methotrexate “metronomic” chemotherapy for the palliative treatment of metastatic breast cancer. A comparative pharmacoeconomic evaluation of novel chemotherapy strategies. Ann Oncol 2005 Aug;16(8):1243-52
3. Tuccori M, Martini G, Giustizi SE, Salvetti A, Blandizzi C, Del Tacca M. Haemorrhagic gastritis and bleeding following rofecoxib administration. Clin Exp Rheum. 2005 Sep-Oct;23:727-8 
4. Tuccori M, Giovannoni S, Giustizi SE, Blandizzi C, Del Tacca M. Acute severe myopathy following single intravenous infusion of omeprazole. Ann Pharmacother 2006 Feb;40(2):352-3
5. Bocci G, Tuccori M, Emmenegger U, Liguori V, Falcone A, Kerbel RS, Del Tacca M.
Reply to the Letter to the Editor on 'Cost-opportunity analysis in clinical oncology: from the "wild far-west" to a correct integration of the disciplines, avoiding the "war of the worlds"', by D. Tassinari et al. (Ann Oncol 2006; 17: 876) Ann Onc 2006 May 1;17(5):877-8
6. Colucci R, Fornai M, Tuccori M, Antonioli L, Pasqualetti G, Blandizzi C, Del Tacca M. Tolerability profiles of leukotriene receptor antagonists and long-acting β2-adrenoceptor agonists in combination with inhaled corticosteroids for treatment of asthma. A review. J Asthma 2007 Jul-Aug;44(6):411-22
7. Tuccori M, Lombardo G, Lapi F, Vannacci A, Blandizzi C, Del Tacca M. Gabapentin-induced severe myopathy. Ann Pharmacother. 2007 Jul;41(7):1301-5 
8. Blandizzi C, Tuccori M, Colucci R, Gori G, Fornai M, Antonioli L, Ghisu N, Del Tacca M. Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients. Drugs Aging 2008;25(3):197-208
9. Tuccori M, Bresci F, Guidi B, Blandizzi C, Del Tacca M, Di Paolo M. Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis: a case report with review of literature. Ann Pharmacother 2008 Jul;42(7):1112-7
10. Lattanzi L, Danesi R, Lastella M, Mungai F, Di Paolo A, Tuccori M, Cassano GB, Del Tacca M. Serotonin syndrome and the T102 → C polymorphism of the 5-HT2A receptor: a case report. Bipolar Disorders 2008 Jul;10(5):655-6
11. Tuccori M, Guidi B, Carulli G, Blandizzi C, Del Tacca M, Di Paolo M. Severe thrombocytopenia and haemolytic anaemia associated with ciprofloxacin: a case report with fatal outcome. Platelets 2008 Aug;19(5):384-7 
12. Salvo F, Polimeni G, Cutroneo PM, Leone R, Conforti A, Moretti U, Motola D, Tuccori M, Caputi AP. Allergic reactions to oral drugs: a case/non-case study from an Italian spontaneous reporting database (GIF). Pharmacol Res. 2008 Sep-Oct;58(3-4):202-7.
13. Tuccori M, Lapi F, Testi A, Coli D, Moretti U, Vannacci A, Motola D, Salvo F, Rivolta AL, Blandizzi C, Mugelli A, Del Tacca M. Statin-associated psychiatric adverse events: a case/non case evaluation of an Italian database of spontaneous adverse drug reaction reporting. Drug Saf 2008;31(12):1115-23
14. Blandizzi C, Tuccori M, Colucci R, Fornai M, Antonioli L, Narcisa G, Del Tacca M. Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy. Pharmacol Res 2009 Feb;59(2):90-100.
15. Tuccori M, Testi A, Antonioli L, Fornai M, Montagnani S, Ghisu N, Colucci R, Corona T, Blandizzi C, Del Tacca M. Safety concerns associated with the use of serotonin reuptake and other serotonergic/noradrenergic antidepressants during pregnancy: a review. Clin Ther 2009;31(mental health theme issue),1426-1453.
16. Tuccori  M, Focosi D, Blandizzi C, Del Tacca M, Petrini M. Re: "Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials" J Natl Cancer Inst, 2009;101(18):1288-1289
17. Tuccori M, Focosi D, Maggi F, Cosottini M, Meini B, Lena F, Blandizzi C, Del Tacca M, Petrini M. Progressive multifocal leukoencephalopathy: a report of three cases in HIV-negative patients with non-Hodgkin’s lymphomas treated with rituximab. Ann Hematol 2010;89(5):519-523.
18. Leone R, Magro L, Moretti U, Cutroneo P, Moschini M, Motola D, Tuccori M, Conforti A. Data mining of spontaneous reporting database as a tool to identify adverse drug reactions associated with drug-drug interactions. Drug Saf. 2010 Aug 1;33(8):667-75
19. Tuccori M, Guidi B, Montagnani S, Fornai M, Antonioli L, Blandizzi C, Di Paolo M. Transient acute liver failure complicating transurethral resection (TUR) syndrome: a case report. Scand J Urol Nephrol 2010 Sep;44(4):269-72
20. Lapi F, Tuccori M, Motola D, Pugi A, Vietri M, Montanaro M, Vaccheri M, Leoni O, Cocci A, Leone R, Conforti A, Moretti U, Sessa E, Mazzaglia G, Mazzei T, Mugelli A, Vannacci A. Fluoroquinolones Safety Profile: Analysis of Adverse Drug Reactions in Relation to Prescription Data. An Italian pharmacovigilance study using four regional databases. Drug Safety Drug Saf. 2010 Sep 1;33(9):789-99.
21. Focosi D, Tuccori M, Kast RE, Maggi F, Ceccherini-Nelli L, Petrini M. Progressive multifocal leukoencephalopathy: what’s new? Neuroscientist 2010;16:308-323
22. Tuccori M, Montagnani S, Testi A, Ruggiero E, Mantarro S, Scollo C, Pergola A, Fornai M; Antonioli L; Colucci R, Corona T; Blandizzi C. Use of Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Major and Cardiovascular Malformations: An Update. Postgraduate Med 2010 Jul;122(4):49-65.
23. Tuccori M, Focosi D, Blandizzi C, Pelosini M, Montagnani S, Maggi F, Pistello M, Antonioli L, Fornai M, Pepe P, Rossi G, Petrini M. Inclusion of rituximab in treatment protocols for non-Hodgkin lymphomas and the risk of progressive multifocal leukoencephalopathy. Oncologist 2010;15(11):1214-9.
24. Gori G, Spinelli G, Spinelli C, Tuccori M, Blandizzi C, Del Tacca M. Esomeprazole-induced hyperchromograninemia in the absence of concomitant hypergastrinemia. Nat Rev Gastroenterol Hepatol 2010 Nov;7(11):642-6.
25. Montagnani S, Tuccori M, Lombardo G, Testi A, Mantarro S, Ruggiero E, Blandizzi C. Autoimmune haemolytic anemia following MF59-adjuvanted influenza vaccine administration: a report of two cases. Ann Pharmacother. 2011 Jan;45(1):e8.
26. Cristiani C, Tuccori M, Pepe P, Sarteschi A, Maddalo F, Simonini G, Michi P, Consigli V, Fornai M, Antonioli L, Blandizzi C. Safety of MF-59 adjuvanted vaccine for pandemic influenza: Results of the vaccination campaign in an Italian health district. Vaccine. 2011 Apr 18;29(18):3443-8.
27. Tuccori M, Lapi F, Testi A, Ruggiero E, Moretti U, Vannacci A, Bonaiuti R, Antonioli L, Fornai M, Giustarini G, Scollo C, Corona T, Ferrazin F, Sottosanti L, Blandizzi C. Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting. Drug Saf. 2011 Oct 1;34(10):849-59.
28. Lazzeri D, Agostini T, Bocci G, Giannotti G, Fanelli G, Naccarato AG, Danesi R, Tuccori M, Pantaloni M, D’Aniello C. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity. Clin Breast Cancer. 2011 Oct;11(5):283-96.
29. Tuccori M, Pisani C, Bachini L, Pardini M, Mantarro S, Antonioli L, Fornai M, Rubinelli M, Cirinei C, Blandizzi C. Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases. Dermatology. 2012;224(3):212-4.
30. Manganelli S, Rossi M, Tuccori M, Galeazzi M. Guillain-Barré syndrome following adalimumab treatment. Clin Exp Rheumatol. 2012 Jul-Aug;30(4):592.
31. Mantarro S, Tuccori M, Pasqualetti G, Tognini S, Montagnani S, Monzani F, Blandizzi C. Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient. BMC Geriatr. 2012 Nov 13;12(1):69-74. [Epub ahead of print]
32. Kast RE, Boockvar JA, Brüning A, Cappello F, Chang WW, Cvek B, Dou QP, Duenas A, Efferth T, Focosi D, Ghaffari SH, Karpel-Massler G, Ketola K, Khoshnevisan A, Keizman D, Magné N, Marosi C, McDonald K, Muñoz M, Paranjpe A, Pourgholami MH, Sardi I, Sella A, Srivenugopal KS, Tuccori M, Wang W, Wirtz CR, Halatsch ME. A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care. Oncotarget. 2013 Apr 13. [Epub ahead of print]
33. Tuccori M, Giustarini G, Blandizzi C, Capogrosso-Sansone A, Rossi M, Gori G, Scarpini F, Mantarro S, Montagnani S, Vannacci A, Antonioli L, Fornai M, Lapi F. Quality of Adverse Drug Reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance. Journal of Public Health (Germany) 21 (4) , pp. 365-372
34. Pugi A, Bonaiuti R, Maggini V, Moschini M, Tuccori M, Leone R, Rossi M, Motola D, Piccinni C, Ferrazin F, Sottosanti L, Mugelli A, Vannacci A, Lapi F. Safety profile of antiviral medications: A pharmacovigilance study using the Italian spontaneous-reporting database. Am J Health Syst Pharm. 2013 Jun 15;70(12):1039-1046.
35. Tuccori M, Montagnani S, Mantarro S, Capogrosso-Sansone A, Ruggiero E, Saporiti A, Antonioli L, Fornai M, Blandizzi C. Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management. CNS Drugs 2014 (accepted – in press)
 

Avvisi Polo1 - DSIS

Università di Pisa